New heart pump device tested in emergency shock patients

NCT ID NCT07293923

Recruiting now Disease control Sponsor: Magenta Medical Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This early study is testing a new heart pump device (Magenta Elevate) in 10 people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The device is inserted through a blood vessel to help the heart pump. Researchers are checking if it is safe and can quickly improve blood pressure and stability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magenta Elevate™ percutaneous left ventricular assist device (pLVAD) system
What this could lead to: If this device works well, it could offer a new way to temporarily support the heart in people with cardiogenic shock, helping stabilize them while they recover.
What could go wrong: This is a very early feasibility study with only 10 participants, so results may not apply to all patients. The device is new and could have unexpected complications or fail to improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction cardiogenic shock heart failure Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI) CARDIOGENIC SHOCK HEART FAILURE

Contacts and locations

Locations

Beilinson Medical Center
RECRUITING

Petah Tikva, Israel
Israeli-Georgian Medical Research Clinic Helsicore
RECRUITING

Tbilisi, Georgia
Meir Medical Center
RECRUITING

Kfar Saba, Israel
Rambam Medical Center
RECRUITING

Haifa, Israel
Shamir Medical Center
RECRUITING

Be’er Ya‘aqov, Israel
Sheba Medical Center
RECRUITING

Ramat Gan, Israel
Tbilisi Heart Center
RECRUITING

Tbilisi, Georgia
Tel-Aviv Sourasky Medical Center
RECRUITING

Tel Aviv, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.